Preoperative cystoscopy could determine the severity of placenta accreta spectrum disorders: An observational study

Aim In the surgical treatment of placenta accreta spectrum disorders, cystoscopy for prophylactic stent placement is performed to protect the ureters from potential injury. Despite its frequent use, the use of cystoscopy in assessing the severity of these disorders has not been explored. Our objecti...

Full description

Saved in:
Bibliographic Details
Published in:The journal of obstetrics and gynaecology research Vol. 45; no. 1; pp. 126 - 132
Main Authors: Al‐Khan, Abdulla, Guirguis, George, Zamudio, Stacy, Alvarez, Manuel, Martimucci, Kristina, Luke, Davlyn, Alvarez‐Perez, Jesus
Format: Journal Article
Language:English
Published: Kyoto, Japan John Wiley & Sons Australia, Ltd 01-01-2019
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim In the surgical treatment of placenta accreta spectrum disorders, cystoscopy for prophylactic stent placement is performed to protect the ureters from potential injury. Despite its frequent use, the use of cystoscopy in assessing the severity of these disorders has not been explored. Our objective was to find out if the abnormal findings documented during cystoscopy are associated with disease severity. Methods In this retrospective, observational cohort study (n = 56), the bladder wall was evaluated at the time of ureteral stent placement via cystoscopy in prenatally diagnosed placenta accreta spectrum cases. Three abnormal findings were commonly present in these cases: bulging of the posterior bladder wall, neovascularization and arterial pulsatility in the area of neovascularization. These findings were stratified according to severity in histologically confirmed specimens. Continuous variables were compared via two‐tailed t‐tests and Wilcoxon rank sum tests. Categorical data were evaluated using logistic regression analysis. Results Neovascularization affected 84%, bulging 71% and pulsatility 54% of the cases. Bulging and neovascularization increased with disease severity. Pulsatility occurred exclusively in percretas. Bulging was associated with a 12‐fold (OR = 11.6, 95% CI 2.94–46.33, P = 0.0005) increased likelihood of percreta and neovascularization with a 17‐fold (OR = 17.06, 95% CI 2.98–97.79, P = 0.0014) increase. Neovascularization and/or the presence of bulging of the bladder have high positive predictive value for placenta increta and percreta (91.5% and 95.0%, respectively). Cystoscopy can be used to assess the severity of placenta accreta spectrum cases preoperatively, especially when placentation is over the previous uterine scar and is in proximity to the bladder wall.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ISSN:1341-8076
1447-0756
DOI:10.1111/jog.13794